Welcome to the 2021 LUPUS CORA Meeting Program Scheduling

The meeting will officially run on Central European Summer Time (CEST), GMT +2

To convert the meeting times to your local time Click Here

 

Displaying One Session

LUPUS Topics || ASC10 INNATE AND ADAPTIVE IMMUNITY, LUPUS Topics || ASC21 REGISTRIES AND COHORTS, No Topic Needed

Session Type
Parallel Session (Lupus)
Date
Sat, 09.10.2021
Session Time
12:30 - 14:30
Room
Hall 1
Chair(s)
  • Thomas Dörner (Germany)
  • Anne Davidson (United States of America)

The importance of immune and local factors in the expression of kidney injury

Presenter
  • George C C. Tsokos (United States of America)
Lecture Time
12:30 - 12:45

Live Q&A

Lecture Time
12:45 - 13:00

The role of pentraxin in LN – more than a biomarker?

Presenter
  • MARIELE GATTO (Italy)
Lecture Time
13:00 - 13:15

Live Q&A

Lecture Time
13:15 - 13:30

Pseudo-antiviral immunity drives LN: is IFN the right target even for LN

Presenter
  • Hans-Joachim Anders (Germany)
Lecture Time
13:30 - 13:45

Live Q&A

Lecture Time
13:45 - 14:00

A NEUTROPHIL DEGRANULATION SIGNATURE IDENTIFIES PROLIFERATIVE LUPUS NEPHRITIS.

Presenter
  • Andrea Fava (United States of America)
Lecture Time
14:00 - 14:06

Abstract

Background and Aims

The identification of intrarenal pathological processes is key to develop better diagnostic and treatment strategies in lupus nephritis (LN). The direct study of renal tissue can be limited by degradation, availability, and cell survival. We employed urine proteomics to define the molecular pathways involved in proliferative LN.

Methods

We quantified 1200 biomarkers (RayBiotech) in urine samples collected on the day of (73%) or within 3 weeks (27%) of kidney biopsy in SLE patients with urine protein to creatinine ratio on random or 24 hr collection of > .5. Protein concentrations were normalized by urine creatinine.

Results

A total of 195 patients were included: 138 (71%) had a proliferative histological class (III or IV +/- V), 57 (29%) pure membranous (V). There were 21 (FDR 1%) differentially abundant urinary proteins in proliferative compared to pure membranous LN (Figure 1A). These included several neutrophil granule proteins (Figure 1B) in addition to previously reported biomarkers such as IL-16 and CD163. Unsupervised clustering based on the proliferative LN signature identified 3 groups characterized by low, medium or high protein abundance (Figure 2). Higher proliferative signature abundance (right cluster) was associated with higher histological activity (NIH Activity Index). Immunofluorescence confirmed an abundant MPO+ neutrophil infiltrate in proliferative LN (Figure 3).

Conclusions

Proliferative LN was associated with a urinary neutrophil degranulation signature, especially in patients with higher histological activity. Neutrophil activity could be noninvasively monitored to assist with the diagnosis of proliferative LN. These findings implicate neutrophils in LN pathogenesis and support the study of treatment targeted to neutrophils.

f1.png

fig3.jpg

f3.png

Hide

Live Q&A

Lecture Time
14:06 - 14:10

CLINICAL AND GENETIC RISK FACTORS ASSOCIATED WITH THE PRESENCE OF LUPUS NEPHRITIS

Presenter
  • Jung min Shin (Korea, Republic of)
Lecture Time
14:10 - 14:16

Abstract

Background and Aims

To elucidate whether clinical features and the weighted genetic risk score (wGRS) were associated with the presence of lupus nephritis (LN).

Methods

We retrospectively divided patients with systemic lupus erythematosus (SLE, n = 1,078) into biopsy-proven LN (n = 507) and non-LN groups (non-LN, n = 571). Baseline clinical features, serologic markers, and the wGRS were collected. The wGRS was calculated from 112 non-HLA loci and HLA-DRβ1 amino acid haplotypes for SLE. Associations among clinical features, wGRS, and the presence of LN were identified.

Results

In the multivariate analysis, patients with LN were younger at diagnosis (odds ratio (OR) = 0.97, p < 0.001), had more pleuritis (OR = 2.44, p < 0.001) and pericarditis (OR = 1.62, p = 0.029), had a higher detection rate of anti-double stranded deoxyribonucleic acid (anti-dsDNA antibodies, OR = 2.22, p < 0.001), anti-Smith antibodies (anti-Sm antibodies, OR = 1.70, p = 0.002), low level of complement (OR = 1.37, p = 0.043) and absence of antiphospholipid antibodies (aPL antibodies, OR = 1.60, p = 0.002), and had higher wGRS (OR = 1.16, p = 0.012). Mediation analysis suggested that anti-Sm antibodies and low complement could be mediators in the relationship between high wGRS and the presence of LN.

Conclusions

Onset age, pleuritis, pericarditis, several serologic markers, and wGRS were associated with the presence of LN. Anti-Sm antibodies and low complement appeared to mediate the indirect relationship between wGRS and the presence of LN.

Hide

Live Q&A

Lecture Time
14:16 - 14:20